DE60335960D1 - 1,2,4-triazolderivat, verfahren zu dessenherstellung, und dieses enthaltende pharmazeutische zusammensetzung - Google Patents

1,2,4-triazolderivat, verfahren zu dessenherstellung, und dieses enthaltende pharmazeutische zusammensetzung

Info

Publication number
DE60335960D1
DE60335960D1 DE60335960T DE60335960T DE60335960D1 DE 60335960 D1 DE60335960 D1 DE 60335960D1 DE 60335960 T DE60335960 T DE 60335960T DE 60335960 T DE60335960 T DE 60335960T DE 60335960 D1 DE60335960 D1 DE 60335960D1
Authority
DE
Germany
Prior art keywords
pharmaceutical composition
composition containing
production
triazole derivative
derivative process
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60335960T
Other languages
English (en)
Inventor
Il-Hwan Cho
Dong-Hyun Ko
Myeong-Yun Chae
Tae-Rho Kim
Kyoung-Rae Kang
Jong-Hoon Kim
Sung-Hak Jung
Sang-Wook Park
Hyung-Ok Chun
Hyung-Chul Ryu
Ji-Young Noh
Hyun-Jung Park
Jie-Eun Park
Young-Mee Chung
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
CJ CheilJedang Corp
Original Assignee
CJ CheilJedang Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by CJ CheilJedang Corp filed Critical CJ CheilJedang Corp
Application granted granted Critical
Publication of DE60335960D1 publication Critical patent/DE60335960D1/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
    • C07D249/10—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D407/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00
    • C07D407/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings
    • C07D407/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
DE60335960T 2002-11-21 2003-07-29 1,2,4-triazolderivat, verfahren zu dessenherstellung, und dieses enthaltende pharmazeutische zusammensetzung Expired - Lifetime DE60335960D1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
KR10-2002-0072688A KR100470075B1 (ko) 2002-11-21 2002-11-21 1,2,4-트리아졸 유도체, 그 제조방법 및 약제학적 조성물
PCT/KR2003/001514 WO2004046121A1 (en) 2002-11-21 2003-07-29 1,2,4-triazole derivative, method for preparing the same, and pharmaceutical composition containing the same

Publications (1)

Publication Number Publication Date
DE60335960D1 true DE60335960D1 (de) 2011-03-17

Family

ID=36539274

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60335960T Expired - Lifetime DE60335960D1 (de) 2002-11-21 2003-07-29 1,2,4-triazolderivat, verfahren zu dessenherstellung, und dieses enthaltende pharmazeutische zusammensetzung

Country Status (10)

Country Link
US (1) US6849652B1 (de)
EP (1) EP1567508B1 (de)
JP (1) JP4348300B2 (de)
KR (1) KR100470075B1 (de)
CN (1) CN100355738C (de)
AT (1) ATE497497T1 (de)
AU (1) AU2003256091A1 (de)
DE (1) DE60335960D1 (de)
ES (1) ES2357834T3 (de)
WO (1) WO2004046121A1 (de)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100491317B1 (ko) * 2002-11-26 2005-05-24 씨제이 주식회사 1,2,4-트리아졸 유도체, 그 제조방법 및 약제학적 조성물
KR100470076B1 (ko) * 2002-11-27 2005-02-05 씨제이 주식회사 1,2,4-트리아졸 유도체, 그 제조방법 및 약제학적 조성물
MY142651A (en) * 2003-03-18 2010-12-15 Merck Sharp & Dohme Biaryl substituted triazoles as sodium channel blockers
KR100576343B1 (ko) * 2004-07-22 2006-05-03 씨제이 주식회사 1,2,4-트리아졸 유도체, 그 제조방법 및 약제학적 조성물
WO2008033466A2 (en) * 2006-09-14 2008-03-20 Combinatorx (Singapore) Pre. Ltd. Compositions and methods for treatment of viral diseases

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4075341A (en) * 1974-05-24 1978-02-21 Gruppo Lepetit S.P.A. 2-Substituted phenyl-5-triazols [5,1-a] isoquinoline compounds
US4259504A (en) * 1979-08-27 1981-03-31 American Cyanamid Company Substituted 1H-1,2,4-triazoles
EP0051084A1 (de) * 1980-11-04 1982-05-12 American Cyanamid Company Substituierte 1H-1,2,4-Triazole
DE4240587A1 (de) * 1992-12-03 1994-06-09 Bayer Ag Verfahren zur Herstellung von Polycarbonaten
US5474995A (en) 1993-06-24 1995-12-12 Merck Frosst Canada, Inc. Phenyl heterocycles as cox-2 inhibitors
US5466823A (en) 1993-11-30 1995-11-14 G.D. Searle & Co. Substituted pyrazolyl benzenesulfonamides
US5434178A (en) * 1993-11-30 1995-07-18 G.D. Searle & Co. 1,3,5 trisubstituted pyrazole compounds for treatment of inflammation
US5908852A (en) * 1994-11-14 1999-06-01 G. D. Searle & Co. 1,3,5 trisubstituted pyrazole compounds for treatment of inflammation
US5633272A (en) 1995-02-13 1997-05-27 Talley; John J. Substituted isoxazoles for the treatment of inflammation
EP1109551A4 (de) * 1998-08-21 2004-10-20 Competitive Tech Inc 4-amino-3-mescapto-1,2,4-triazole
EP1099695A1 (de) * 1999-11-09 2001-05-16 Laboratoire Theramex S.A. 5-Aryl-1H-1,2,4-triazolverbindungen als Cyclooxygenase-2 Inhibitoren und diese enthaltende pharmazeutische Zusammensetzungen
US6451820B1 (en) * 2000-03-23 2002-09-17 Boehringer Ingelheim Pharmaceuticals, Inc. Substituted 1-(4-aminophenly)triazoles and their use as anti-inflammatory agents
DE10123586A1 (de) * 2001-05-08 2002-11-28 Schering Ag 3,5-Diamino-1,2,4-triazole als Kinase Inhibitoren

Also Published As

Publication number Publication date
EP1567508B1 (de) 2011-02-02
EP1567508A4 (de) 2008-12-10
KR100470075B1 (ko) 2005-02-05
CN1717397A (zh) 2006-01-04
ATE497497T1 (de) 2011-02-15
KR20040044614A (ko) 2004-05-31
CN100355738C (zh) 2007-12-19
US6849652B1 (en) 2005-02-01
EP1567508A1 (de) 2005-08-31
WO2004046121A1 (en) 2004-06-03
JP2006514631A (ja) 2006-05-11
JP4348300B2 (ja) 2009-10-21
AU2003256091A1 (en) 2004-06-15
ES2357834T3 (es) 2011-05-03

Similar Documents

Publication Publication Date Title
TW200724136A (en) Pharmaceutical compositions comprising PPAR modulator
HUP0400636A2 (hu) Azetidinszármazékokat tartalmazó gyógyszerkészítmények, új azetidinszármazékok és előállításuk
RS51444B (sr) JEDINJENJA KOJA SADRŽE LAKTAM I NJIHOVI DERIVATI KAO INHIBITORI FAKTORA Xa
ME00440B (me) Novi $g(b kristalni oblik tercijalne butilaminske soli perindoprila, postupak dobijanja i farmaceutske kompozicije koje sadrže isto
GEP20104964B (en) 3-aminocarbazole compounds, pharmaceutical composition containing the same and method for the preparation thereof
DE602004009200D1 (de) Tetrahydrochinazolinderivate als cfr-antagonisten
ATE372995T1 (de) Benzo(b)(1,4)dioxepinderivate
JO2413B1 (en) Benzoxazine derivatives and their use
SE0300908D0 (sv) Azaindole derivatives, preparations thereof, uses thereof and compositions containing them
CA2494321A1 (en) 1,2,4-triazole derivative, method for preparing the same, and pharmaceutical composition containing the same
CY1105939T1 (el) Παραγωγα βενζοθειαζινης και βενζοθεαδιαζινης, μεθοδος παρασκευης αυτων και φαρμακευτικες συνθεσεις οι οποιες τα πepιεχουν
MXPA04005484A (es) Procedimiento de preparacion de derivados de equinocandina.
SE0300105D0 (sv) Diarylmethylidene piperdine derivatives, preparations thereof and uses thereof
DE60335960D1 (de) 1,2,4-triazolderivat, verfahren zu dessenherstellung, und dieses enthaltende pharmazeutische zusammensetzung
EA200300272A1 (ru) Новые производные хиназолина, способ их получения и фармацевтические композиции, содержащие их
PL361850A1 (en) Novel lipoic acid heterocyclic or benzene derivatives, preparation and use thereof as medicines
SG149005A1 (en) Process for the preparation of thiazolopyrimidines
EA200400409A1 (ru) Новые соединения изохинолина, способ их получения и фармацевтические композиции, содержащие их
YU81502A (sh) Ciklopostini, postupak za njihovu proizvodnju i njihova primena
ATE365162T1 (de) Tetrahydropyridyl-alkyl-heterozykle, verfahren zu ihrer herstellung und pharmazeutische zusammensetzungen die sie enthalten
MXPA05005340A (es) Nuevos derivados antagonistas del receptor de la vitronectina, sus procedimientos de preparacion, su aplicacion como medicamentos y los compuestos farmaceuticos que los contienen.
SE0301445D0 (sv) Diarylmethylidene piperidine derivatives, preparations thereof and uses thereof
SE0300104D0 (sv) Diarylmethylidene piperidine derivatives, preparations thereof and uses thereof
SE0300103D0 (sv) Diarylmethylidene piperidine derivatives, preparations thereof and uses thereof
EA200100155A3 (ru) Новые производные 6-амино или 6-гидразиносульфонил-3-хинолинилфосфоновой кислоты, способ их получения и содержащие их фармацевтические композиции